Peer-Reviewed Literature Synthesis

COPD Biomarker Atlas

Molecular alterations reported in COPD compared to healthy controls, from peer-reviewed literature.

Literature Overview

Biomarkers below are included only where peer-reviewed literature explicitly reports the marker's direction in COPD patients relative to a named comparison population — not inferred.

5
Curated markers
2
Categories

Searchable Alterations Database

Comparison populations are quoted as reported in the source literature (e.g. healthy controls, disease-matched patients).

Marker / TestDirectionCategoryvs. ComparisonClinical ContextKey Reference

Key References

Peer-Reviewed Literature

Dasi et al. 2024

DOI: 10.1016/j.medcli.2023.10.014 →
Peer-Reviewed Literature

Yanbaeva et al. 2007

DOI: 10.1378/chest.06-2179 →
Peer-Reviewed Literature

Liu et al. 2025

DOI: 10.2147/COPD.S534060 →
Disclaimer: Educational synthesis of peer-reviewed literature only — not medical advice. Markers are drawn from published disease-vs-comparison-population studies; inclusion here does not imply diagnostic or clinical validation. Consult a qualified healthcare professional for interpretation.

Individual COPD biomarker pages

Each COPD marker has its own page with direction, comparison group, symptoms, test details, citation and FAQ. Browse all marker pages.

Inflammatory

Pulmonary

Cite this page

Reusing these data? Please cite the tracker so others can find the source.

Open Source Medicine Foundation. (2026). COPD Biomarkers: 5 Blood Tests & Lab Markers. Research Tracker. https://research.opensourcemed.info/copd-biomarkers.html (accessed )

Weekly post-viral research digest

New peer-reviewed studies and trial activity across Long COVID, ME/CFS, PACVS, Lyme and Gulf War Illness, every week. Free, no spam.

Subscribe on Substack   Browse the digest archive · RSS